Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 28 Sep 2023

Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer

in Molecular and Cellular Oncology

Qian Yu
Susumu S. Kobayashi
Hiroshi Haeno

Frontiers in Oncology

doi 10.3389/fonc.2023.1137966

3,682 views

Editorial

Published on 28 Sep 2023

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

in Molecular and Cellular Oncology

Giulia Adriani
Paola Cappello
Sara Lovisa

Frontiers in Oncology

doi 10.3389/fonc.2023.1289756

2,651 views
1 citation

Perspective

Published on 26 Sep 2023

Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?

in Molecular and Cellular Oncology

Pierluigi Scalia
Stephen J. Williams

Frontiers in Oncology

doi 10.3389/fonc.2023.1278402

2,386 views
1 citation

Review

Published on 26 Sep 2023

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

in Molecular and Cellular Oncology

Pu Xia
Anna Dubrovska

Frontiers in Oncology

doi 10.3389/fonc.2023.1251100

17,024 views
25 citations

Review

Published on 26 Sep 2023

Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy

in Molecular and Cellular Oncology

Yoon-Jin Lee
Shinwon Chae
Dongsic Choi

Frontiers in Oncology

doi 10.3389/fonc.2023.1256585

6,567 views
24 citations

Review

Published on 22 Sep 2023

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

in Molecular and Cellular Oncology

Li Lin
Qing Wu
Feifei Lu
Jiaming Lei
Yanhong Zhou
Yifei Liu
Ni Zhu
You Yu
Zhifeng Ning
Tonghui She

Frontiers in Oncology

doi 10.3389/fonc.2023.1184079

27,778 views
107 citations

Review

Published on 21 Sep 2023

Evolution by innovation as a driving force to improve TCR-T therapies

in Molecular and Cellular Oncology

Dolores J. Schendel

Frontiers in Oncology

doi 10.3389/fonc.2023.1216829

8,806 views
5 citations

Review

Published on 20 Sep 2023

Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors

in Molecular and Cellular Oncology

Deena Elsori
Gowhar Rashid
Nihad Ashraf Khan
Punya Sachdeva
Riya Jindal
Falak Kayenat
Bhuvi Sachdeva
Mohammad Azhar Kamal
Asaad Ma Babker
Sherif Ashraf Fahmy

Frontiers in Oncology

doi 10.3389/fonc.2023.1265347

9,166 views
33 citations

Correction

Published on 20 Sep 2023

Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study

in Molecular and Cellular Oncology

Masahide Isowa
Reo Hamaguchi
Ryoko Narui
Hiromasa Morikawa
Hiromi Wada

Frontiers in Oncology

doi 10.3389/fonc.2023.1291026

1,234 views

Mini Review

Published on 19 Sep 2023

Post-translational modifications and their implications in cancer

in Molecular and Cellular Oncology

Hashnu Dutta
Nishant Jain

Frontiers in Oncology

doi 10.3389/fonc.2023.1240115

14,707 views
69 citations

Original Research

Published on 19 Sep 2023

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics

in Molecular and Cellular Oncology

Wei Liu
Junkan Zhu
Zhen Wu
Yongxiang Yin
Qiao Wu
Yiming Wu
Jiaojiao Zheng
Cong Wang
Hongyan Chen
Talal Jamil Qazi

Frontiers in Oncology

doi 10.3389/fonc.2023.1269751

6,240 views
9 citations

Mini Review

Published on 18 Sep 2023

Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies

in Molecular and Cellular Oncology

Kohei Okuyama
Hiromasa Fukushima
Tomofumi Naruse
Souichi Yanamoto

Frontiers in Oncology

doi 10.3389/fonc.2023.1248097

3,425 views
6 citations

Original Research

Published on 13 Sep 2023

Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

in Molecular and Cellular Oncology

Lucie M. Frerichs
Bastian Frerichs
Patrick Petzsch
Karl Köhrer
Joachim Windolf
Bernd Bittersohl
Michèle J. Hoffmann
Vera Grotheer

Frontiers in Oncology

doi 10.3389/fonc.2023.1228185

4,078 views
9 citations

Review

Published on 12 Sep 2023

The multifaceted roles of matrix metalloproteinases in lung cancer

in Molecular and Cellular Oncology

Cui Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1195426

5,849 views
35 citations

Original Research

Published on 11 Sep 2023

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma

in Molecular and Cellular Oncology

Nilmary Grafals-Ruiz
Annelis O. Sánchez-Álvarez
Yasmarie Santana-Rivera
Eunice L. Lozada-Delgado
Robert J. Rabelo-Fernandez
Christian I. Rios-Vicil
Fatima Valiyeva
Pablo E. Vivas-Mejia

Frontiers in Oncology

doi 10.3389/fonc.2023.1249649

4,477 views
11 citations

Review

Published on 11 Sep 2023

Progress in investigating the relationship between Schlafen5 genes and malignant tumors

in Molecular and Cellular Oncology

Teng Tu
Ye Yuan
Xiaoxue Liu
Xin Liang
Xiaofan Yang
Yue Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1248825

2,838 views
4 citations

Editorial

Published on 08 Sep 2023

Editorial: Epigenetic insights into diagnostic and therapeutic applications

in Molecular and Cellular Oncology

Elisabetta Fratta
Carmen Jerónimo
Antionette S. Perry
Samantha G. Pattenden

Frontiers in Oncology

doi 10.3389/fonc.2023.1284535

1,887 views

Review

Published on 08 Sep 2023

Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications

in Molecular and Cellular Oncology

Ying Liu
Wei Ding
Jianxun Wang
Xiang Ao
Junqiang Xue

Frontiers in Oncology

doi 10.3389/fonc.2023.1256537

5,322 views
55 citations

Original Research

Published on 08 Sep 2023

Abl kinases can function as suppressors of tumor progression and metastasis

in Molecular and Cellular Oncology

Melissa A. Marchal
Devon L. Moose
Afshin Varzavand
Nicole E. Jordan
Destiney Taylor
Munir R. Tanas
James A. Brown
Michael D. Henry
Christopher S. Stipp

Frontiers in Oncology

doi 10.3389/fonc.2023.1241056

2,998 views
1 citation

Review

Published on 08 Sep 2023

Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma

in Molecular and Cellular Oncology

Zhuoran Wang
Nan Li
Peng Cai
Cunzhen Zhang
Guangwen Cao
Jianhua Yin

Frontiers in Oncology

doi 10.3389/fonc.2023.1249198

4,298 views
11 citations

Review

Published on 07 Sep 2023

The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review

in Molecular and Cellular Oncology

Xu Zhang
Peng Jiang
Chaojun Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1127637

7,056 views
13 citations

Systematic Review

Published on 07 Sep 2023

The diagnostic value of machine learning for the classification of malignant bone tumor: a systematic evaluation and meta-analysis

in Molecular and Cellular Oncology

Yue Li
Bo Dong
Puwei Yuan

Frontiers in Oncology

doi 10.3389/fonc.2023.1207175

3,919 views
9 citations

Editorial

Published on 04 Sep 2023

Editorial: Women in molecular and cellular oncology

in Molecular and Cellular Oncology

Petranel T. Ferrao
Laura Rosanò
Valeria Poli
Shilpa S. Dhar
Ana Paula Lepique

Frontiers in Oncology

doi 10.3389/fonc.2023.1257780

1,965 views

Editorial

Published on 01 Sep 2023

Editorial: Women in molecular and cellular oncology, volume II: 2022

in Molecular and Cellular Oncology

Shilpa S. Dhar

Frontiers in Oncology

doi 10.3389/fonc.2023.1272365

1,615 views

3,144 articles

articles

Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance

Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Evolution by innovation as a driving force to improve TCR-T therapies

Nanotube breakthroughs: unveiling the potential of carbon nanotubes as a dual therapeutic arsenal for Alzheimer’s disease and brain tumors

Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study

Post-translational modifications and their implications in cancer

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics

Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies

Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

The multifaceted roles of matrix metalloproteinases in lung cancer

MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma

Progress in investigating the relationship between Schlafen5 genes and malignant tumors

Editorial: Epigenetic insights into diagnostic and therapeutic applications

Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications

Abl kinases can function as suppressors of tumor progression and metastasis

Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma

The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review

The diagnostic value of machine learning for the classification of malignant bone tumor: a systematic evaluation and meta-analysis

Editorial: Women in molecular and cellular oncology

Editorial: Women in molecular and cellular oncology, volume II: 2022